122 results on '"Krance, R.A."'
Search Results
2. Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome
3. Chimeric Antigen Receptor Gene-Modified Virus-Specific T-Cell Expanded in Patients with Reactivated Epstein-Barr Virus Post Allogeneic Stem Cell Transplant
4. A Phase 1 Perspective: Multivirus-Specific T Cells From Both Cord Blood and Bone Marrow Transplant Donors
5. Safety and clinical efficacy of rapidly-generated virus-specific T cells with activity against adv, EBV, CMV, HHV6 and BK virus administered after allogeneic hematopoietic stem cell transplant
6. 9 - Chimeric Antigen Receptor Gene-Modified Virus-Specific T-Cell Expanded in Patients with Reactivated Epstein-Barr Virus Post Allogeneic Stem Cell Transplant
7. 7 - A Phase 1 Perspective: Multivirus-Specific T Cells From Both Cord Blood and Bone Marrow Transplant Donors
8. Ultra low-dose IL-2 mediated expansion of regulatory T cells as GvHD prophylaxis for recipients of allogeneic hematopoietic stem cells
9. Infusion of CD19-directed/multivirus specific-cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation for B cell malignancies
10. Robust T-cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy
11. Immune Reconstitution in Children Receiving Cord Blood Transplantation (CBT) Without the Use of Lymphocytolytic Antibodies
12. Safety and Persistence of Infused CD19-Car-Modified Multivirus Specific CTLs in B Cell Malignancies Post Allogeneic Hematopoietic Stem Cell Transplantation
13. A Novel Severe Combined Immunodeficiency (SCID) Mutation in Three Mexican Siblings with additional de novo Duchenne Muscular Dystrophy (DMD) mutation
14. Adoptive Transfer of Rapidly-Generated Multivirus-Specific T Cells to Treat Adenovirus, EBV and CMV Infections of Hematopoietic Stem Cell Transplant Recipients
15. Ultra Low-Dose Il-2 Mediated Expansion of Regulatory T Cells as GVHD Prophylaxis for Recipients of Allogeneic Hematopoietic Stem Cells
16. Haploidentical Stem Cell Transplants in Children With Acute Lymphoblastic Leukemia in First or Second Remission
17. The Clinical Use of Cord Blood-Derived Virus-Specific Cytotoxic T Lymphocytes Reactive Against Cytomegalovirus (CMV), Adenovirus, and Epstein-Barr Virus (EBV)
18. Allogeneic Stem Cell Transplantation for Chronic Active EBV infection (CAEBV)
19. Weight-Based Dosing of Valganciclovir in Pediatric HSCT Recipients
20. Children With Acute Leukemia: A Comparison Of Outcomes From Allogeneic Blood Stem Cell And Bone Marrow Transplantation
21. CMV Elimination in DiGeorge Syndrome Following Matched Related Stem Cell Transplant
22. The Costs And Cost-Effectiveness Of Allogeneic Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation In Pediatric Patients With Acute Leukemia
23. Outcomes of 48 Severe Combined Immunodeficiency Patients Treated with Hematopoietic Stem Cell Transplantation at a Single Center Between 1981 and 2007
24. Expansion Of Regulatory T Cells With Ultra Low-Dose Il-2 After Allogeneic Hematopoietic Stem Cell Transplantation
25. 223: Alternative Donor Hematopoietic Stem Cell Transplantation for Pediatric Patients with Acute Lymphoblastic Leukemia Using Campath in a Myeloablative Conditioning Regimen
26. 188: Single Institution's Outcomes for First Transplant as Salvage Therapy for Hodgkin's Lymphoma
27. 41: Long-term follow up of T cell depleted transplants from unrelated donors in pediatric patients
28. 1: Cytotoxic T lymphocyte therapy for the treatment and prevention of adenovirus infection after stem cell transplant
29. 221: A submyeloablative regimen of Campath-1H and Fludarabine for patients with graft failure following allogeneic transplantation from MHC identical or near identical donors
30. 252: Outcome of allogeneic hematopoietic stem cell transplantation for pediatric patients with chronic myeloid leukemia
31. Cytomegalovirus (CMV) infection in patients receiving either alemtuzumab (CAMPATH 1-H) or antithymocyte globulin (ATG) as graft-versus-host disease (GVHD) prophylaxis prior to allogeneic stem cell transplantation (SCT)
32. The clinical use of donor-derived virus-specific cytotoxic T lymphocytes reactive against cytomegalovirus (CMV), adenovirus, and epstein barr virus (EBV)
33. Hepatic arterial resistance index — An indicator of diffuse liver disease in children treated with bone marrow transplantation
34. Induction of hepatic drug metabolism during high dose preparative chemotherapy for bone marrow transplantation(BMT).
35. Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1
36. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
37. Gene marking after bone marrow transplantation
38. Tretinoin toxicity in children with acute promyelocytic leukaemia
39. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients
40. Correction of Duncan's syndrome by allogeneic bone marrow transplantation
41. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
42. Serial Lymphocyte Expressions with Unusual and Discordant Distribution of Cellular Populations in the Periphery and Skin in Pre-Transplant Reticular Dysgenesis
43. An Approach for the Analysis of Relapse and Marrow Reconstitution After Autologous Marrow Transplantation Using Retrovirus-Mediated Gene Transfer
44. Total Body Irradiation and High-Dose Etoposide: A New Preparatory Regimen for Bone Marrow Transplantation in Patients With Advanced Hematologic Malignancies
45. Outcome of alternative donor transplantation for severe aplastic anemia can be comparable to outcome with matched related donors
46. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes
47. 207Allogeneic bone marrow transplantation for children with hematologic malignancies
48. 203Allogeneic bone marrow transplantation for children with myeloid hematologic malignancies
49. Transferred gene expression after autologous bone marrow transplantation in man
50. Long-term repopulation with EBV-responsive T cells following adoptive transfer of gene-modified virus-specific T lymphocytes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.